Ignite Creation Date:
2025-12-25 @ 2:36 AM
Ignite Modification Date:
2025-12-30 @ 5:11 PM
Study NCT ID:
NCT05850234
Status:
RECRUITING
Last Update Posted:
2025-08-06
First Post:
2023-04-18
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of GC012F (AZD0120), a CAR T Therapy Targeting CD19 and BCMA in Subjects With Relapsed/Refractory Multiple Myeloma
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-07-20
Start Date Type:
ACTUAL
Primary Completion Date:
2027-08-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-11-15
Completion Date Type:
ESTIMATED
First Submit Date:
2023-04-18
First Submit QC Date:
None
Study First Post Date:
2023-05-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-05
Last Update Post Date:
2025-08-06
Last Update Post Date Type:
ACTUAL